SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166
- 15 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (38), 6085-6098
- https://doi.org/10.1038/s41388-020-01419-4
Abstract
The mechanistic basis of liver metastasis in colorectal cancer remains poorly understood. We previously reported that the sclerostin domain containing-1 (SOSTDC1) protein is overexpressed in the secretome of metastatic colorectal cancer cells and can inhibit liver homing. Here, we investigated the mechanisms of SOSTDC1 for promoting invasiveness and progression of colorectal cancer liver metastasis. SOSTDC1 inhibition of BMP4 maintains the expression of cancer stem cell traits, including SOX2 and NANOG. Immunoprecipitation and mass spectrometry analyses reveal the association of SOSTDC1 with ALCAM/CD166, which was confirmed by confocal microscopy and competition ELISA. Interaction with ALCAM is mediated by the N-terminal region of SOSTDC1, which contains a sequence similar to the ALCAM-binding motif used by CD6. Knocking down either SOSTDC1 or ALCAM expression, or using blocking antibodies, reduces the invasive activity by inhibiting Src and PI3K/AKT signaling pathways. In addition, ALCAM interacts with the α2ß1 and α1ß1 integrins, providing a possible link to Src activation. Finally, inoculation of SOSTDC1-silenced metastatic cells increases mouse survival by inhibiting liver metastasis. In conclusion, SOSTDC1 promotes invasion and liver metastasis in colorectal cancer, by overcoming BMP4-specific antimetastatic signals and inducing ALCAM-mediated Src and PI3K/AKT activation. These experiments underscore the potential of SOSTDC1 as a therapeutic target in metastatic colorectal cancer.Funding Information
- Ministerio de Economía y Competitividad (BIO2015-66489-R)
- Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (RTI2018-095055-B100)
- Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PRB3 (ISCIII-SGEFI/FEDER-PT17/0019/0008))
- Fundación Ramón Areces
This publication has 45 references indexed in Scilit:
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis InitiationCancer Cell, 2012
- Control of the Embryonic Stem Cell StateCell, 2011
- The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone MetastasisPLOS ONE, 2011
- SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancerBreast Cancer Research and Treatment, 2010
- Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP SignalsOnline Journal of Public Health Informatics, 2009
- Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapseBritish Journal of Cancer, 2009
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumorsNature Genetics, 2008
- A Human Bone Morphogenetic Protein Antagonist Is Down-Regulated in Renal CancerMolecular Biology of the Cell, 2008
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidneyBiochemical and Biophysical Research Communications, 2004